David Sandoval

563 total citations
29 papers, 431 citations indexed

About

David Sandoval is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, David Sandoval has authored 29 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Rheumatology, 22 papers in Immunology and 7 papers in Hematology. Recurrent topics in David Sandoval's work include Spondyloarthritis Studies and Treatments (26 papers), Psoriasis: Treatment and Pathogenesis (22 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). David Sandoval is often cited by papers focused on Spondyloarthritis Studies and Treatments (26 papers), Psoriasis: Treatment and Pathogenesis (22 papers) and Rheumatoid Arthritis Research and Therapies (20 papers). David Sandoval collaborates with scholars based in United States, Canada and United Kingdom. David Sandoval's co-authors include Victor L. J. Tybulewicz, Reuben Tooze, Douglas T. Fearon, Martin Turner, Robert H. Carter, Theresa Hunter, G S Alarcón, Atul Deodhar, Krista Schroeder and Rebecca Bolce and has published in prestigious journals such as Immunity, Annals of the Rheumatic Diseases and Journal of the American Academy of Dermatology.

In The Last Decade

David Sandoval

28 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Sandoval United States	11	288	246	100	51	27	29	431
Annie Cartman Canada	10	139 0.5×	251 1.0×	51 0.5×	36 0.7×	10 0.4×	10	383
Sybille Arnold Germany	10	191 0.7×	275 1.1×	49 0.5×	64 1.3×	44 1.6×	12	442
Alexandra Wactor United States	5	102 0.4×	59 0.2×	54 0.5×	82 1.6×	25 0.9×	6	232
Jison Hong United States	7	127 0.4×	75 0.3×	29 0.3×	83 1.6×	7 0.3×	10	325
Jessica Herrath Sweden	8	214 0.7×	109 0.4×	29 0.3×	46 0.9×	21 0.8×	8	326
TRDJ Radstake Netherlands	10	97 0.3×	118 0.5×	47 0.5×	43 0.8×	35 1.3×	20	268
Shinichiro Nakachi Japan	10	177 0.6×	93 0.4×	25 0.3×	50 1.0×	14 0.5×	11	342
Souichiro Nakano Japan	9	229 0.8×	126 0.5×	29 0.3×	34 0.7×	15 0.6×	21	322
Alice Lorenzi United Kingdom	8	143 0.5×	124 0.5×	39 0.4×	28 0.5×	20 0.7×	12	272
Shanrun Liu United States	11	164 0.6×	55 0.2×	43 0.4×	147 2.9×	39 1.4×	21	384

Countries citing papers authored by David Sandoval

Since Specialization

Citations

This map shows the geographic impact of David Sandoval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sandoval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sandoval more than expected).

Fields of papers citing papers by David Sandoval

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sandoval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sandoval. The network helps show where David Sandoval may publish in the future.

Co-authorship network of co-authors of David Sandoval

This figure shows the co-authorship network connecting the top 25 collaborators of David Sandoval. A scholar is included among the top collaborators of David Sandoval based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sandoval. David Sandoval is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maksymowych, Walter P., Rebecca Bolce, Gaia Gallo, et al.. (2022). Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging. Lara D. Veeken. 61(11). 4324–4334. 10 indexed citations

Coates, Laura C., Philip J. Mease, David Sandoval, et al.. (2022). Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results. Clinical Rheumatology. 41(10). 3035–3047. 13 indexed citations

Horst‐Bruinsma, Irene van der, Kurt de Vlam, Jessica A. Walsh, et al.. (2022). Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials. Advances in Therapy. 39(6). 2806–2819. 7 indexed citations

Maksymowych, Walter P., Xenofon Baraliakos, R. Lambert, et al.. (2022). Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis. The Lancet Rheumatology. 4(9). e626–e634. 15 indexed citations

Merola, Joseph F., et al.. (2022). 31057 Ixekizumab treatment response: Consistency over time and at each visit in psoriatic arthritis. Journal of the American Academy of Dermatology. 87(3). AB177–AB177. 1 indexed citations

Braun, Jürgen, Uta Kiltz, Atul Deodhar, et al.. (2022). Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST. RMD Open. 8(2). e002165–e002165. 10 indexed citations

Heijde, Désirée van der, Mikkel Østergaard, John D. Reveille, et al.. (2021). Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years. The Journal of Rheumatology. 49(3). 265–273. 25 indexed citations

Deodhar, Atul, Philip J. Mease, Helena Marzo‐Ortega, et al.. (2021). Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks. BMC Rheumatology. 5(1). 50–50. 3 indexed citations

Hunter, Theresa, David Sandoval, Nicola Booth, Elizabeth Holdsworth, & Atul Deodhar. (2021). Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey. Clinical Rheumatology. 40(8). 3161–3167. 18 indexed citations

10.

Deodhar, Atul, Philip J. Mease, Proton Rahman, et al.. (2020). Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial. Rheumatology and Therapy. 8(1). 135–150. 11 indexed citations

11.

Deodhar, Atul, David Sandoval, Elizabeth Holdsworth, Nicola Booth, & Theresa Hunter. (2020). Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States. Rheumatology and Therapy. 7(2). 415–423. 5 indexed citations

12.

Marzo‐Ortega, Helena, Philip J. Mease, Proton Rahman, et al.. (2020). Impact of Ixekizumab on Work Productivity in Patients with Ankylosing Spondylitis: Results from the COAST-V and COAST-W Trials at 52 Weeks. Rheumatology and Therapy. 7(4). 759–774. 7 indexed citations

13.

Marzo‐Ortega, Helena, Philip J. Mease, Proton Rahman, et al.. (2020). THU0396 IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM THE COAST-V AND COAST-W TRIALS AT 52 WEEKS. Annals of the Rheumatic Diseases. 79. 433–434. 1 indexed citations

14.

Hunter, Theresa, Krista Schroeder, David Sandoval, & Atul Deodhar. (2019). Persistence, Discontinuation, and Switching Patterns of Newly Initiated TNF Inhibitor Therapy in Ankylosing Spondylitis Patients in the United States. Rheumatology and Therapy. 6(2). 207–215. 19 indexed citations

15.

Mease, Philip J., Jessica A. Walsh, Xenofon Baraliakos, et al.. (2019). Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis. Rheumatology and Therapy. 6(3). 435–450. 17 indexed citations

16.

Sandoval, David, et al.. (2019). Diagnostic precision of sentinel lymph node biopsy in penile cancer. Indian Journal of Urology. 35(4). 282–282. 4 indexed citations

17.

Walsh, Jessica A., Theresa Hunter, Krista Schroeder, David Sandoval, & Rebecca Bolce. (2019). Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006–2016. BMC Rheumatology. 3(1). 39–39. 34 indexed citations

18.

Vlam, Kurt de, Joseph F. Merola, Julie Birt, et al.. (2018). Skin Involvement in Psoriatic Arthritis Worsens Overall Disease Activity, Patient-Reported Outcomes, and Increases Healthcare Resource Utilization: An Observational, Cross-Sectional Study. Rheumatology and Therapy. 5(2). 423–436. 17 indexed citations

19.

Tooze, Reuben, Martin Turner, David Sandoval, et al.. (1998). CD19 as a Membrane-Anchored Adaptor Protein of B Lymphocytes: Costimulation of Lipid and Protein Kinases by Recruitment of Vav. Immunity. 8(5). 635–645. 155 indexed citations

20.

Sandoval, David, et al.. (1995). Adverse Events in Methotrexate-Treated Rheumatoid Arthritis Patients. Lara D. Veeken. XXXIV(suppl 4). 49–56. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact